Evaluation of long term effectiveness of Platelet rich plasma in plantar fasciitis

Evaluation of long term effectiveness of single injection of Platelet rich plasma in plantar fasciitis A Retrospective cum prospective study - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080861

Enrollment

Registered

2025-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

Intervention1: Platelet Rich plasma: Platelet Rich plasma is composed of indigenous blood products centrifused to aggregate platelets and growth factors, the Total duration from collection of blood to

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients clinically diagnosed with plantar fasciitis of foot

Exclusion criteria

Exclusion criteria: Less than 18 years of age Any injection site skin lesions Severe infection Bleeding disorder Malignancy Pregnancy Previous surgery

Design outcomes

Primary

Measure	Time frame
To identify and treat cases of plantar fasciitis with single intraarticular injection of platelet Rich plasmaTimepoint: Outcomes will be assessed at 1 month,2months,3 months, 6 months and 12 months	—

Secondary

Measure	Time frame
To study the long term effectiveness in terms of VAS & Roles & maudsley scoreTimepoint: Outcomes will be assessed at 1 month,2months,3 months, 6 months & 12 months	—

Countries

India

Contacts

Public ContactDr Pragyesh Jain

Teerthankar Mahaveer Medical College and Research Centre Moradabad Uttar Pradesh

manmohan500@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026